Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
7.1%
% of IXJ's 112 holdings also in OZEM
34.8%
% of OZEM's 23 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.2% | 14.2% | 8.2% |
 |
ROCHE HOLDING LTD | 2.8% | 4.9% | 2.8% |
|
AMGEN INC | 2.1% | 3.2% | 2.1% |
|
PFIZER INC | 2.0% | 3.0% | 2.0% |
|
REGENERON PHARMACEUTICALS | 1.1% | 2.3% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to OZEM
|
UNITEDHEALTH GROUP INC | 7.6% |
|
JOHNSON & JOHNSON | 4.9% |
 |
NOVO NORDISK A/S-B | 4.4% |
|
ABBVIE INC | 4.1% |
|
MERCK & CO. INC. | 3.4% |
|
NOVARTIS AG | 2.8% |
|
ABBOTT LABORATORIES | 2.8% |
|
THERMO FISHER SCIENTIFIC INC | 2.7% |
 |
ASTRAZENECA PLC | 2.7% |
|
INTUITIVE SURGICAL INC | 2.6% |
IXJ Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -16.9% |
|
ELI LILLY & CO | -6.0% |
|
ZEALAND PHARMA A/S | -4.6% |
|
ALTIMMUNE, INC. | -4.6% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.2% |
|
ASTRAZENECA PLC-SPONS ADR | -3.9% |
|
VIKING THERAPEUTICS, INC. | -3.3% |
 |
INNOVENT BIOLOGICS, INC. | -3.2% |
|
SCHOLAR ROCK HOLDING CORP. | -2.7% |
 |
HANMI PHARM CO LTD | -2.5% |